Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.49 | N/A |
| PEG Ratio (TTM) | -2.35 | N/A |
| P/S Ratio (TTM) | 0.22 | N/A |
| P/B Ratio (TTM) | 0.97 | N/A |
| P/FCF Ratio (TTM) | 43.27 | N/A |
| Price to 5YR AVG Earnings Ratio | 59.27 | N/A |
| Price to 5YR AVG FCF Ratio | -47.15 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.19% | N/A |
| ROE (TTM) | 5.61% | N/A |
| Net Profit Margin (TTM) | 1.01% | N/A |
| ROIC 5YR AVG | 5.33% | N/A |
Growth (20%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -14.68% | -190.12% | -91.75% |
| Revenue | 0.09% | -3.78% | 0.73% |
| Net Income | -14.53% | -194.03% | -93.96% |
| Cash Flow | 71.33% | -45.82% | 38.19% |
Health (49%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.45 | N/A |
| Quick Ratio (TTM) | 1.26 | N/A |
| D/E Ratio (TTM) | 1.97 | N/A |
| Interest Coverage (TTM) | 1.92 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.31 | N/A |
| LTL to 5YR AVG FCF | -84.01 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.07% | N/A |